3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma
4
Neoplasm Metastasis
3
Multiple Myeloma
3
Ovarian Neoplasms
2
Endometrial Neoplasms
2
Breast Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Neoplasms
1
Melanoma
1
Malignant Solid Neoplasm
1
Lymphoma, Mantle-Cell
1
Lymphoma, B-Cell, Marginal Zone
1
Lung Neoplasms
1
Hematologic Neoplasms
1
HER2 Positive Breast Cancer
1
Glioma
1
Fallopian Tube Neoplasms
1
Esophageal Neoplasms
1
Disease Progression
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Interventions
Specimen Handling
3
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Ipilimumab
2
CTLA-4 Antigen
2
olaparib
1
durvalumab
1
defactinib
1
cediranib
1
capivasertib
1
Restraint, Physical
1
RO5126766
1
Immunoglobulin G
1
Hysterectomy
1
Fluid Therapy
1
Disulfides
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Endometrioid
×
copanlisib
×
90 days
×
Clear all
No trials found.